Stock Research for CCXI

CCXI

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

CCXI Stock Chart & Research Data

The CCXI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CCXI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


CCXI Due diligence Resources & Stock Charts

The CCXI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CCXI Detailed Price Forecast - CNN Money CNN View CCXI Detailed Summary - Google Finance
Yahoo View CCXI Detailed Summary - Yahoo! Finance Zacks View CCXI Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View CCXI Trends & Analysis - Trade-Ideas Barrons View CCXI Major Holders - Barrons
NASDAQ View CCXI Call Transcripts - NASDAQ Seeking View CCXI Breaking News & Analysis - Seeking Alpha
Spotlight View CCXI Annual Report - CompanySpotlight.com OTC Report View CCXI OTC Short Report - OTCShortReport.com
TradeKing View CCXI Fundamentals - TradeKing Charts View CCXI SEC Filings - Bar Chart
WSJ View Historical Prices for CCXI - The WSJ Morningstar View Performance/Total Return for CCXI - Morningstar
MarketWatch View the Analyst Estimates for CCXI - MarketWatch CNBC View the Earnings History for CCXI - CNBC
StockMarketWatch View the CCXI Earnings - StockMarketWatch MacroAxis View CCXI Buy or Sell Recommendations - MacroAxis
Bullish View the CCXI Bullish Patterns - American Bulls Short Pains View CCXI Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View CCXI Stock Mentions - StockTwits PennyStocks View CCXI Stock Mentions - PennyStockTweets
Twitter View CCXI Stock Mentions - Twitter Invest Hub View CCXI Investment Forum News - Investor Hub
Yahoo View CCXI Stock Mentions - Yahoo! Message Board Seeking Alpha View CCXI Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for CCXI - SECform4.com Insider Cow View Insider Transactions for CCXI - Insider Cow
CNBC View CCXI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CCXI - OTC Markets
Yahoo View Insider Transactions for CCXI - Yahoo! Finance NASDAQ View Institutional Holdings for CCXI - NASDAQ


Stock Charts

FinViz View CCXI Stock Insight & Charts - FinViz.com StockCharts View CCXI Investment Charts - StockCharts.com
BarChart View CCXI Stock Overview & Charts - BarChart Trading View View CCXI User Generated Charts - Trading View


Latest Financial News for CCXI

Free Research Report as ChemoCentryx’s Quarterly Revenues Zoomed More than 1000%; Turned Profitable Y-O-Y
Posted on Thursday April 19, 2018

LONDON, UK / ACCESSWIRE / April 19, 2018 / Active-Investors.com has just released a free earnings report on ChemoCentryx, Inc. (NASDAQ: CCXI). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=CCXI. The Company reported its fourth quarter fiscal 2017 and full fiscal year 2017 operating and financial results on March 14, 2018.


Should You Be Tempted To Sell ChemoCentryx Inc (NASDAQ:CCXI) At Its Current PE Ratio?
Posted on Thursday April 12, 2018

ChemoCentryx Inc (NASDAQ:CCXI) is trading with a trailing P/E of 32.9x, which is higher than the industry average of 27.1x. While CCXI might seem like a stock to avoid orRead More...


ChemoCentryx Announces Presentation During National Kidney Foundation 2018 Spring Clinical Meeting
Posted on Wednesday April 11, 2018

MOUNTAIN VIEW, Calif., April 11, 2018-- ChemoCentryx, Inc.,, today announced the presentation of positive safety, efficacy and quality of life results from the Company’ s successfully completed Phase II ...


Recent Analysis Shows Ericsson, Toronto Dominion Bank, Odonate Therapeutics, Colliers International Group, ChemoCentryx, and CyberArk Software Market Influences — Renewed Outlook, Key Drivers of Growth
Posted on Tuesday April 10, 2018

NEW YORK, April 10, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...


Enter a stock symbol to view the stock details.